慢性阻塞性肺疾病稳定期的抗炎治疗现状

The Status of Anti-inflammatory Treatment of Chronic Obstructive Pulmonary Disease in Stabilization Period

慢性阻塞性肺疾病是临床严重的慢性呼吸系统疾病,患者患病人数多,其病死率高,且疾病为慢性进展性的发展,并会严重地影响患者的生活质量。慢性阻塞性肺疾病患者在急性发作期后,会出现症状缓解阶段,其肺功能持续恶化,并会有自身防御能力降低,容易被外界感染。在慢性阻塞性肺疾病的稳定期治疗时,需要给予戒烟,支气管舒张药物,祛痰药物,糖皮质激素治疗,家庭氧疗等,有学者还提出要使用抗炎资料。本文综述了临床在慢性阻塞性肺疾病稳定期的抗炎治疗现状,提供学者进行参考和借鉴。

Chronic obstructive pulmonary disease is the severity chronic respiratory disease in clinical. The number of sick patients,the mortality rate are high, and the disease is a chronic progressive development,and will seriously effect the quality of patients＇ life. Patients with chronic obstructive pul monary disease after acute stage,lung function continued to deteriorate,and would have to reduce its own defense capabilities, easily infected by the outside world.Treatment in stabilization period of chronic obstructive pulmonary disease,you need to be given smoking cessation, bronchodilator drugs, expectorant drugs, glucocorticoid therapy and home oxygen therapy.Some scholars also have proposed the use of anti-inflammatory information.This article reviews the clinical status in the anti-inflammatory treatment for chronic obstructive pulmonary disease in stabilization period providing reference for scholars.